InVivoMAb anti-mouse IL-12 p35
BE0371
ApplicationsImmunoPrecipitation, ELISA, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-12 p35
- Delivery Days Customer7
- ApplicationsImmunoPrecipitation, ELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDC18.2
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2a
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Tang W, Wang H, Claudio E, et al. The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells. Immunity. 2014,41(4):555-66. doi: 10.1016/j.immuni.2014.09.017Read this paper
- Bitsaktsis C, Babadjanova Z, Gosselin EJ. In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model. Infect Immun. 2015,83(1):77-89. doi: 10.1128/IAI.02289-14Read this paper
- Collison LW, Pillai MR, Chaturvedi V, et al. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol. 2009,182(10):6121-8. doi: 10.4049/jimmunol.0803646Read this paper
- Meyts I, Hellings PW, Hens G, et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol. 2006,177(9):6460-70.Read this paper
- Sutterwala FS, Noel GJ, Salgame P, et al. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med. 1998,188(1):217-22.Read this paper
